Daiwa Capital Markets America’s Gilead Sciences GILD Stock Holding History

Daiwa Capital Markets America’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$3.32M	Buy	+44,200	New	+$3.08M	0.03%	167

Other funds holding GILD

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Daiwa Capital Markets America's GILD Position: Q4 2013 in Review

Daiwa Capital Markets America opened a new position in Gilead Sciences (GILD) in Q4 2013: 44,200 shares worth $3.32M. The stake represents 0.03% of the portfolio and ranks #167 among its holdings.

1,100 funds tracked by Wall St. Rank hold GILD as of Q4 2013.

Daiwa Capital Markets America held 44,200 shares of Gilead Sciences worth $3.32M as of Q4 2013.
Gilead Sciences was a new Daiwa Capital Markets America position in Q4 2013.
Gilead Sciences made up 0.03% of Daiwa Capital Markets America's portfolio in Q4 2013, its #167 holding.
1,100 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2013.

Based on Daiwa Capital Markets America's 13F filing for Q4 2013, filed 13 Feb 2014.